Mirae Asset Global Etfs Holdings Ltd. Rapt Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,853 shares of RAPT stock, worth $18,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,853
Previous 17,073
4.57%
Holding current value
$18,210
Previous $26,000
19.23%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Medicxi Ventures Management (Jersey) LTD22.4MShares$22.8 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$13.4 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$13.4 Million3.85% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$12.8 Million8.35% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$12 Million0.24% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $30.2M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...